Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value: $2.057B (100.0% shares, 0.0% debt)

Holdings (39)

BMRN BIOMARIN PHARMACEUTICAL INC 10.9%
Value $223M Shares 2,606,485 Share Price $85.65 Est. Cost/Share $80.19 Unrealized @ Report Date +6.7%
INSM INSMED INC 9.8%
Value $202M Shares 7,890,917 Share Price $25.60 * Est. Cost/Share $17.16 Unrealized @ Report Date +62.3%
— ABIOMED INC 8.9%
Value $184M Shares 706,354 Share Price $260.49 Est. Cost/Share $37.80 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 7.1%
Value $146M Shares 795,031 Share Price $183.09 Est. Cost/Share $48.62 Unrealized @ Report Date —
— ALEXION PHARMACEUTICALS INC 6.5%
Value $134M Shares 1,023,780 Share Price $130.98 Est. Cost/Share $121.54 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 6.1%
Value $124M Shares 4,237,051 Share Price $29.38 Est. Cost/Share $13.06 Unrealized @ Report Date +121.0%
UTHR UNITED THERAPEUTICS CORP DEL 5.9%
Value $121M Shares 1,552,792 Share Price $78.06 * Est. Cost/Share $88.73 Unrealized @ Report Date +5.4%
FOLD AMICUS THERAPEUTICS INC 4.7%
Value $97.3M Shares 7,796,299 Share Price $12.48 Est. Cost/Share $7.54 Unrealized @ Report Date +68.3%
— IMMUNOMEDICS INC 4.5%
Value $92.61M Shares 6,676,755 Share Price $13.87 Est. Cost/Share $13.38 Unrealized @ Report Date —
— EPIZYME INC 4.2%
Value $87.03M Shares 6,935,074 Share Price $12.55 Est. Cost/Share $15.12 Unrealized @ Report Date —
— WRIGHT MED GROUP N V 4.0%
Value $82.64M Shares 2,771,394 Share Price $29.82 Est. Cost/Share $23.42 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 3.9%
Value $79.71M Shares 3,828,564 Share Price $20.82 Est. Cost/Share $22.84 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 3.7%
Value $76.45M Shares 5,141,304 Share Price $14.87 Est. Cost/Share $51.30 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 3.5%
Value $71.23M Shares 5,055,050 Share Price $14.09 * Est. Cost/Share $11.21 Unrealized @ Report Date +42.0%
ACAD ACADIA PHARMACEUTICALS INC 3.0%
Value $61.71M Shares 2,308,803 Share Price $26.73 * Est. Cost/Share $27.34 Unrealized @ Report Date -6.6%
ALGN ALIGN TECHNOLOGY INC 2.0%
Value $40.37M Shares 147,505 Share Price $273.70 * Est. Cost/Share $114.31 Unrealized @ Report Date +164.2%
EXAS EXACT SCIENCES CORP 1.8%
Value $37.17M Shares 314,889 Share Price $118.04 * Est. Cost/Share $13.61 Unrealized @ Report Date +640.1%
— AMAG PHARMACEUTICALS INC 1.6%
Value $33.72M Shares 3,375,506 Share Price $9.99 Est. Cost/Share $29.07 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 1.5%
Value $31.52M Shares 5,262,263 Share Price $5.99 Est. Cost/Share $17.42 Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 1.2%
Value $23.89M Shares 1,919,313 Share Price $12.45 Est. Cost/Share $14.06 Unrealized @ Report Date —
— ALDER BIOPHARMACEUTICALS INC 1.1%
Value $21.91M Shares 1,861,630 Share Price $11.77 Est. Cost/Share $11.48 Unrealized @ Report Date —
PBYI PUMA BIOTECHNOLOGY INC 0.9%
Value $17.87M Shares 1,405,680 Share Price $12.71 * Est. Cost/Share $28.90 Unrealized @ Report Date -20.3%
GILD GILEAD SCIENCES INC 0.6%
Value $11.88M Shares 175,900 Share Price $67.56 * Est. Cost/Share $62.02 Unrealized @ Report Date -18.1%
PRTA PROTHENA CORP PLC 0.6%
Value $11.72M Shares 1,108,510 Share Price $10.57 * Est. Cost/Share $32.98 Unrealized @ Report Date -68.9%
— RIGEL PHARMACEUTICALS INC 0.5%
Value $10.4M Shares 3,985,945 Share Price $2.61 Est. Cost/Share $3.40 Unrealized @ Report Date —
KLDO KALEIDO BIOSCIENCES INC 0.5%
Value $10.05M Shares 866,666 Share Price $11.60 * Est. Cost/Share $13.76 Unrealized @ Report Date +5.8%
— CELGENE CORP 0.5%
Value $9.88M Shares 106,883 Share Price $92.44 Est. Cost/Share $89.02 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.3%
Value $5.226M Shares 331,813 Share Price $15.75 Est. Cost/Share $5.39 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.1%
Value $2.682M Shares 3,013,793 Share Price $0.89 Est. Cost/Share $4.88 Unrealized @ Report Date —
— ZOGENIX INC 0.1%
Value $1.41M Shares 29,500 Share Price $47.80 Est. Cost/Share $13.36 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.1%
Value $1.391M Shares 123,686 Share Price $11.25 * Est. Cost/Share $6.71 Unrealized @ Report Date +43.6%
— SUNESIS PHARMACEUTICALS INC 0.0%
Value $845K Shares 1,162,473 Share Price $0.73 Est. Cost/Share $4.37 Unrealized @ Report Date —
— MARINUS PHARMACEUTICALS INC 0.0%
Value $520K Shares 125,321 Share Price $4.15 Est. Cost/Share $4.17 Unrealized @ Report Date —
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value $441K Shares 73,500 Share Price $6.00 * Est. Cost/Share $7.53 Unrealized @ Report Date 0.0%
— SOPHIRIS BIO INC 0.0%
Value $209K Shares 247,000 Share Price $0.85 Est. Cost/Share $2.60 Unrealized @ Report Date —
— IDERA PHARMACEUTICALS INC 0.0%
Value $206K Shares 77,044 Share Price $2.67 Est. Cost/Share $8.90 Unrealized @ Report Date —
— MINERVA NEUROSCIENCES INC 0.0%
Value $204K Shares 36,319 Share Price $5.62 Est. Cost/Share $5.62 Unrealized @ Report Date —
— MELINTA THERAPEUTICS INC 0.0%
Value $67,000 Shares 10,137 Share Price $6.61 Est. Cost/Share $3.55 Unrealized @ Report Date —
— HISTOGENICS CORP 0.0%
Value $58,000 Shares 302,922 Share Price $0.19 Est. Cost/Share $11.00 Unrealized @ Report Date —